Technology
Health
Pharmaceutical

Axsome Therapeutics

$24.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.16 (4.92%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell AXSM and other stocks, options, ETFs, and crypto commission-free!

About

Axsome Therapeutics, Inc. Common Stock, also called Axsome Therapeutics, is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Read More Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Employees
29
Headquarters
New York, New York
Founded
2012
Market Cap
823.61M
Price-Earnings Ratio
β€”
Dividend Yield
0.00
Average Volume
948.68K
High Today
$25.36
Low Today
$24.02
Open Price
$24.25
Volume
556.18K
52 Week High
$25.80
52 Week Low
$1.94

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
Biopharmaceutical
2015 IPO
US

News

BenzingaMay 8

Axsome Therapeutics, - 4 Stocks Breaking Out On Earnings & Other News

Here are four stocks to watch with strong technical momentum fueled by earnings and other news. Axsome Therapeutics, Inc. (NASDAQ: AXSM) gained 39 cents to $19.54 on Tuesday on 1.4 million shares. The biotech company announced Monday that the FDA granted Breakthrough Therapy Designation for its therapy for major depressive disorder. The stock has been a huge climber this year, starting the year under $3. After flagging in the last week, it looks poised to continue the uptrend, with the next target towards ...

1,595
NasdaqMay 7

What's in Store for Axsome (AXSM) This Earnings Season?

Axsome Therapeutics, Inc. AXSM is scheduled to report first-quarter 2019 earnings results on May 9, 2019, before the market opens. The company's performance over the trailing four quarters has been encouraging with its earnings having surpassed expectations twice while meeting the same just once. The average trailing four-quarter beat is 3.03%. In the las t report ed quarter, Axsome delivered a positive surprise of 3.03%. Shares of Axsome have skyrocketed 579.1% so far this year, outperforming the industr...

600
NasdaqMay 6

Health Care Sector Update for 05/06/2019: ESPR, AXSM, CANF, JNJ, PFE, ABT, MRK, AMGN

Top Health Care Stocks: JNJ: -1.05% PFE: -0.89% ABT: -1.83% MRK: -1.54% AMGN: -1.10% Monday pre-market saw lower health care majors. Stocks moving on news include: (+) Esperion Therapeutics ( ESPR ), which was more than 11% higher after the the Food and Drug Administration accepted its new drug applications (NDAs) for bempedoic acid and the bempedoic acid/ezetimibe combination tablet for the treatment of low-density lipoprotein cholesterol (LDL-C) in patients who need additional LDL-C lowering despi...

165

Earnings

-$0.34
-$0.29
-$0.24
-$0.19
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
β€”
Actual
Expected Aug 7, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.